Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Investing Activities: 2020-2024

Historic Cash from Investing Activities for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$604,000.

  • Burning Rock Biotech's Cash from Investing Activities rose 24.76% to -$386,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$967,000, marking a year-over-year decrease of 6.85%. This contributed to the annual value of -$604,000 for FY2024, which is 53.86% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Cash from Investing Activities is -$604,000, which was up 53.86% from -$1.3 million recorded in FY2023.
  • Burning Rock Biotech's Cash from Investing Activities' 5-year high stood at $12.8 million during FY2021, with a 5-year trough of -$16.8 million in FY2020.
  • Its 3-year average for Cash from Investing Activities is -$998,333, with a median of -$1.1 million in 2022.
  • As far as peak fluctuations go, Burning Rock Biotech's Cash from Investing Activities soared by 176.55% in 2021, and later tumbled by 108.44% in 2022.
  • Burning Rock Biotech's Cash from Investing Activities (MRY) stood at -$16.8 million in 2020, then skyrocketed by 176.55% to $12.8 million in 2021, then plummeted by 108.44% to -$1.1 million in 2022, then decreased by 20.98% to -$1.3 million in 2023, then skyrocketed by 53.86% to -$604,000 in 2024.
  • Its Cash from Investing Activities stands at -$604,000 for FY2024, versus -$1.3 million for FY2023 and -$1.1 million for FY2022.